People · Operator
Named in public records as an officer, director or promoter · active 2010–2015 · Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Yelp Inc | — | Other Technology | Series C | $134.0M | $2.4B | 2012 |
| Emerald Therapeutics, Inc. | — | Other Health Care | Series A | $15.1M | $113.2M | 2010 |
Max R Levchin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Max R Levchin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Keith Rabois | 1 | 25 |
| Peter Fenton | 1 | 16 |
| Jeremy Levine | 1 | 12 |
| Luke R. Nosek | 1 | 2 |
| Keith M Rabois | 1 | 2 |
| Max Levchin | 1 | 2 |
| Robert Krolik | 1 | 2 |
| Peter R Fenton | 1 | 1 |
| Joseph R Nachman | 1 | 1 |
| Geoff Donaker | 1 | 1 |
| Rob Krolik | 1 | 1 |
| Diane M Irvine | 1 | 1 |
| Laurence Wilson | 1 | 1 |
| Robert R Gibbs | 1 | 1 |
| Daniel J. Kleinbaum | 1 | 1 |
| Brian R. Singerman | 1 | 1 |
| Brian J. Frezza | 1 | 1 |
| Brian Frezza | 1 | 1 |
| Jeremy M Levine | 1 | 1 |
| Luke J. Nosek | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.